Newport Pharmaceuticals International

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Newport Pharmaceuticals International sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials none currently recruiting 6 completed upper quartile by trial count

Newport Pharmaceuticals International: 6 sponsored US clinical trials, none currently recruiting.

Newport Pharmaceuticals International sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is HIV Infections, with 3 trials.

Upper-quartile sponsor footprint

Newport Pharmaceuticals International sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

6 total, page 1 of 1

COMPLETED NA

A Study of Isoprinosine in Patients With Severe AIDS

NCT00002295
COMPLETED NA

A Study of Isoprinosine in Patients With Lymph Node Disease

NCT00002297
COMPLETED NA

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy

NCT00002061
COMPLETED NA

The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease

NCT00002296
COMPLETED NA

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

NCT00002059
COMPLETED NA

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)

NCT00002060

Therapeutic Areas

HIV Infections 3
Lymphatic Disease 2

How the Newport Pharmaceuticals International archive is shaped

6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: HIV Infections (3 trials), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Newport Pharmaceuticals International: archived-pipeline peers nationwide

Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Newport Pharmaceuticals International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Newport Pharmaceuticals International23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan Branch10xBio22nd Century Group3-C Institute for Social Development3 Waves Wellness
Newport Pharmaceuticals International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Newport Pharmaceuticals International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Newport Pharmaceuticals International page

6 registered trials is a research-attention snapshot, not an endorsement of Newport Pharmaceuticals International or any single study.

  • None of Newport Pharmaceuticals International's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • HIV Infections is the condition Newport Pharmaceuticals International studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Newport Pharmaceuticals International pipeline card: 6 registered trials from official public datasets.Report a data error.